Tesamorelin is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analog. It was originally developed and approved by the FDA for the treatment of HIV-associated lipodystrophy, a condition characterized by abnormal fat distribution, particularly excess fat buildup in the abdominal area. As a synthetic analog of GHRH, tesamorelin stimulates the pituitary gland to release more endogenous growth hormone (GH), which in turn increases insulin-like growth factor 1 (IGF-1) levels in the body. This hormonal boost has profound effects on metabolism, fat distribution, and even cognitive function.
Tag Archives: Tesamorelin and liver fat reduction.
Tesamorelin: A Peptide for Metabolic Health and Fat Reduction What is Tesamorelin?Tesamorelin is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It works by stimulating the pituitary gland to release more natural growth hormone, thereby boosting the body’s own growth hormone levels. How Does Tesamorelin Work?Tesamorelin binds to GHRH receptors in […]
Tesamorelin: A Targeted Peptide for Metabolic and Hormonal Health What Is Tesamorelin?Tesamorelin is a synthetic peptide that functions as a growth hormone–releasing hormone (GHRH) analog. Rather than supplying growth hormone directly, tesamorelin stimulates the body’s own pituitary gland to naturally produce and release growth hormone (GH). This makes it a more physiologic and regulated approach […]